Jeff Yass’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$795K Sell
232,366
-127,844
-35% -$397K ﹤0.01% 8802
2026
Q1
$821K Buy
360,210
+324,270
+902% +$747K ﹤0.01% 8411
2025
Q4
$101K Sell
35,940
-72,158
-67% -$258K ﹤0.01% 11451
2025
Q3
$519K Sell
108,098
-215,346
-67% -$1.37M ﹤0.01% 8858
2025
Q2
$2.94M Buy
323,444
+227,820
+238% +$1.68M ﹤0.01% 4995
2025
Q1
$863K Buy
95,624
+58,098
+155% +$613K ﹤0.01% 7620
2024
Q4
$490K Sell
37,526
-47,173
-56% -$629K ﹤0.01% 8711
2024
Q3
$1.33M Buy
84,699
+42,256
+100% +$640K ﹤0.01% 6182
2024
Q2
$573K Sell
42,443
-18,395
-30% -$377K ﹤0.01% 7931
2024
Q1
$1.69M Sell
60,838
-12,049
-17% -$268K ﹤0.01% 5733
2023
Q4
$1.4M Sell
72,887
-133,234
-65% -$2.41M ﹤0.01% 6151
2023
Q3
$3.33M Sell
206,121
-75,542
-27% -$1.34M ﹤0.01% 4203
2023
Q2
$5.36M Sell
281,663
-38,149
-12% -$680K ﹤0.01% 3402
2023
Q1
$4.65M Buy
319,812
+264,930
+483% +$4.75M ﹤0.01% 3561
2022
Q4
$1.07M Buy
54,882
+31,322
+133% +$611K ﹤0.01% 6033
2022
Q3
$568K Buy
+23,560
New +$726K ﹤0.01% 8152
2022
Q2
Sell
-9,898
Closed -$359K 13629
2022
Q1
$436K Buy
9,898
+1,960
+25% +$84.2K ﹤0.01% 9324
2021
Q4
$345K Sell
7,938
-89,812
-92% -$3.52M ﹤0.01% 10146
2021
Q3
$3.06M Buy
97,750
+41,786
+75% +$1.64M ﹤0.01% 4905
2021
Q2
$2.37M Buy
55,964
+5,044
+10% +$196K ﹤0.01% 5539
2021
Q1
$1.91M Buy
50,920
+29,555
+138% +$924K ﹤0.01% 6033
2020
Q4
$578K Sell
21,365
-7,384
-26% -$190K ﹤0.01% 7966
2020
Q3
$722K Sell
28,749
-6,101
-18% -$89K ﹤0.01% 6896
2020
Q2
$266K Buy
34,850
+16,405
+89% +$120K ﹤0.01% 8567
2020
Q1
$169K Sell
18,445
-47,787
-72% -$288K ﹤0.01% 8879
2019
Q4
$342K Sell
66,232
-82,737
-56% -$531K ﹤0.01% 7766
2019
Q3
$866K Buy
148,969
+104,259
+233% +$468K ﹤0.01% 6003
2019
Q2
$143K Buy
44,710
+16,046
+56% +$54.7K ﹤0.01% 9407
2019
Q1
$118K Buy
28,664
+13,396
+88% +$84.7K ﹤0.01% 8177
2018
Q4
$97K Sell
15,268
-33,600
-69% -$349K ﹤0.01% 8238
2018
Q3
$807K Sell
48,868
-30,757
-39% -$523K ﹤0.01% 5641
2018
Q2
$1.33M Buy
79,625
+34,654
+77% +$561K ﹤0.01% 4777
2018
Q1
$699K Buy
+44,971
New +$802K ﹤0.01% 5959
2017
Q4
Sell
-44,700
Closed -$991K 9717
2017
Q3
$1.3M Buy
44,700
+26,324
+143% +$777K ﹤0.01% 4755
2017
Q2
$592K Sell
18,376
-824
-4% -$27K ﹤0.01% 6322
2017
Q1
$664K Sell
19,200
-137,505
-88% -$4.91M ﹤0.01% 5963
2016
Q4
$5.53M Buy
+156,705
New +$5.3M ﹤0.01% 2251
2016
Q3
Sell
-7,100
Closed -$249K 8852
2016
Q2
$265K Sell
7,100
-70,500
-91% -$2.65M ﹤0.01% 7160
2016
Q1
$3.14M Sell
77,600
-68,973
-47% -$2.57M ﹤0.01% 2991
2015
Q4
$5.27M Buy
+146,573
New +$5.3M ﹤0.01% 2474
2015
Q3
Sell
-23,968
Closed -$815K 10001
2015
Q2
$815K Buy
+23,968
New +$807K ﹤0.01% 6627
2015
Q1
Sell
-17,927
Closed -$629K 9778
2014
Q4
$629K Buy
17,927
+11,728
+189% +$395K ﹤0.01% 6795
2014
Q3
$203K Sell
6,199
-35,277
-85% -$1.2M ﹤0.01% 8655
2014
Q2
$1.41M Buy
+41,476
New +$1.42M ﹤0.01% 5359
2014
Q1
Sell
-29,194
Closed -$1.07M 9269
2013
Q4
$1.07M Buy
29,194
+14,107
+94% +$518K ﹤0.01% 5397
2013
Q3
$522K Buy
+15,087
New +$528K ﹤0.01% 6352

Other funds holding ACH

Jeff Yass's ACH Position: Q2 2026 in Review

Jeff Yass reduced its Accendra Health (ACH) stake by 35% in Q2 2026, selling an estimated $397K and leaving 232,366 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #8802.

Jeff Yass first reported a position in ACH in Q3 2013 and has held it in 46 quarters since. The position peaked at $5.53M in Q4 2016. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Jeff Yass held 232,366 shares of Accendra Health worth $795K as of Q2 2026.
  • Jeff Yass sold 127,844 Accendra Health shares in Q2 2026, an estimated $397K.
  • Accendra Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8802 holding.
  • Jeff Yass first reported a position in Accendra Health in Q3 2013 and has held it in 46 quarters since.
  • Jeff Yass's Accendra Health position peaked at $5.53M in Q4 2016.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.